Everest Group 3Q 2026: Revenue $3.71B, EPS $6.12— 10-Q Summary

Everest Group reported 3Q 2026 revenue of $3.71B, down 14% YoY, and net income of $233M, down 8.9% YoY. Diluted EPS rose slightly to $6.12. Nine-month premiums earned fell 12.6% to $10.2B, with declines in Reinsurance Treaty and Legacy volumes. The company focused on Reinsurance Treaty and Global Wholesale & Specialty, and launched Annapurna Re. Sales of Canadian, Colombian, and Mexican operations are planned.

Original reporting
Published Oct 30, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Everest Group 3Q 2026: Revenue $3.71B, EPS $6.12— 10-Q Summary — source image
Decision brief

The 30-second read

$EGBearishMed
01

Why it matters

The earnings release shows a contraction in core treaty volumes, prompting concerns about growth momentum.

02

Market read

First disclosure of Q3 2026 results; revenue and profit declines are material for the stock.

03

What to watch

Divestiture of legacy retail operations and new sidecar capacity may improve future profitability.

Relevance 8/10Novelty 8/10Timing: post‑market release

Background

Everest Group is a global reinsurance and specialty insurance provider that files quarterly reports on U.S. exchanges.

Company-level read

Ticker impact

$EGBearishHigh confidence
Context

Everest Group reported Q3 2026 revenue of $3.71B (down 14%) and net income of $233M, with EPS $6.12, marking the first public disclosure of its quarterly results.

Expected impact

downward pressure as investors digest lower revenue and profit despite a marginal EPS increase

Evidence & confidence

Revenue fell 14% YoY and net income fell 8.9%, which typically triggers a sell‑off for a reinsurance firm.

Market effects

Reinsurance sector may see broader scrutiny as earnings highlight soft demand for treaty business.

North American reinsurance markets could experience modest price adjustments.

Limited to insurers and specialty lines; unlikely to affect broader indices.

Counterpoint

The slight EPS beat and focus on specialty lines could support a rebound if the market overreacts to revenue decline.

Key entities

  • Everest Group Ltd.

    Global reinsurance and specialty insurance firm.

Related articles

$EGMed

Everest To Sell Chile Insurance Unit To AIG

Everest Group (EG) is selling its Chile insurance unit to AIG, marking its final planned divestiture in Latin America. The deal is expected to close in the first half of 2027. Everest's shares rose 2.40% to $410.21, while AIG's shares gained 0.14% to $81.55 on NYSE.

$EGMed

Everest Agrees to Sell Chile Insurance to AIG

Everest Group (NYSE: EG) agreed to sell its Chile insurance business to AIG (NYSE: AIG), completing its exit from Latin American commercial retail insurance. The sale follows the recent completion of Everest's Colombia insurance business sale to AIG. The Chile deal is expected to close in the first half of 2027, pending regulatory approvals.

$EGMed

What Everest Group (EG) Said on Its Q3 Earnings Call

Everest Group reported Q3 earnings, highlighting a $600M increase in casualty reserves, with 2/3 tied to North American business. Reinsurance premiums fell 6% YoY. The company's Global Wholesale & Specialty segment saw 3% premium growth and improved margins. Everest repurchased 1.3M shares and returned $550M to shareholders. Management expects continued competition in catastrophe reinsurance and remains selective in casualty.

$EGMed

Everest Group Ltd (EG) (Q3 2026) Earnings Call Highlights: Strengthened Reserves

Everest Group Ltd (EG) reported Q3 2026 earnings, highlighting strengthened reserves and record figures. Management chose not to release all favorable short-tail emergence to maintain balance sheet conservatism. CEO Jim Williamson described the casualty reinsurance environment as 'fairly bearish,' citing U.S. social inflation and rising competition. Casualty pro rata written premium fell 18% in the quarter.